Calamos wealth management analysts tracking fund flows note

Analysts tracking fund flows note Calamos Wealth Management’s allocation to biotech innovators, with sector valuations below 5-year averages but catalysts from FDA approvals on the horizon. The information in each fund's prospectus and statement of additional information) is not complete and may be changed. We may not sell the securities of any fund until such fund's registration statement filed with the Securities and Exchange Commission is effective. Each fund's prospectus and statement of additional information is not an offer to sell such fund's securities and is not soliciting an offer to buy such fund's securities in any state where the offer or sale is not permitted. "Calamos Investments LLC, referred to herein as Calamos Investments ® , is a financial services company offering such services through its subsidiaries: Calamos Advisors LLC, Calamos Wealth Management LLC, Calamos Investments LLP and Calamos Financial Services LLC. With WTI crude stabilizing around $78, Calamos Wealth Management’s energy holdings are positioned for income generation while limiting downside amid global supply shifts.